Therapautic drug level monitoring in clinical practice (1999)
22 September 1999. Related: Archive.
Meeting to review the research that supports wider use of TDM for some NNTRIs and protease inhibitors, especially for individualising care in certain patient groups.
These include children, people with liver or kidney impairment, potential drug interactions where there is limited data and to confirm drug levels before and after dose modification related to side effects.
3rd ATP DrFax symposium.
Download PDF 460 Kb